Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-11 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-10 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-10 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
mRNA | HAX1 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-09 |
mRNA | DCAF6 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | SLC25A20 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |